RBM17 and neoplasm: We found that knockdown of either MSI2 or RBM17 had significant radiosensitizing effects, and MSI2 partially reversed the effect of knockdown of RBM17 on tumor radiosensitivity, while RBM17 significantly reversed the effect of knockdown of MSI2 on tumor sensitivity (Figure 6C,D).